The New Zealand Rugby Judicial Committee has completed an anti-doping hearing for Kalib Hamiora Whakataka resulting in a two-year ban from playing rugby for the possession and use of Clenbuterol.
Whakataka, 30, admitted to the purchase and use of Clenbuterol in 2015 which he said was to aid weight loss and said he was not aware that doing so was an anti-doping violation. He claimed he had not received any information about doping rules and was not playing rugby at the time, although he was registered with Uawa Rugby Football Club.
The committee concluded Whakataka did not understand the risks associated with the use of Clenbuterol but as a registered player he was bound to the anti-doping regulations.
His suspension was backdated to begin on 17 July 2017.
Clenbuterol is a prohibited substance under the New Zealand Sports Anti-Doping Rules.
The charges were brought against Whakataka by Drug Free Sport New Zealand following their investigation which was initiated by Medsafe into the operation of the website Clenbuterol NZ.